{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:01:17Z","timestamp":1781103677088,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.rdc.2016.09.010","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:03:35Z","timestamp":1477094615000},"page":"111-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases"],"prefix":"10.1016","volume":"43","author":[{"given":"Eliza F.","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"RR-5","key":"10.1016\/j.rdc.2016.09.010_bib1","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.rdc.2016.09.010_bib2","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: a 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4065\/82.11.1341","article-title":"A\u00a0population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction","volume":"82","author":"Yawn","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2016.09.010_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/cid\/ciq077","article-title":"Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination","volume":"52","author":"Leung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib6","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1016\/j.vaccine.2006.04.060","article-title":"Variability and gender differences in memory T\u00a0cell immunity to varicella-zoster virus in healthy adults","volume":"24","author":"Klein","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2016.09.010_bib7","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/522123","article-title":"Humor and cellular immunity to varicella-zoster virus: an overview","volume":"197","author":"Arvin","year":"2008","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.rdc.2016.09.010_bib8","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccines and to screen for susceptibility to varicella","volume":"197","author":"Bruer","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1086\/592219","article-title":"Measurement of varicella-zoster virus (VZV)-specific cell-mediated immunity: comparison between VZV skin test and interferon-gamma enzyme-linked immunospot assay","volume":"198","author":"Sadaoka","year":"2008","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib10","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/art.23883","article-title":"Viral infection and reactivation in autoimmune diseases","volume":"58","author":"Chakravarty","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.09.010_bib11","first-page":"2151","article-title":"Association of reduced CD4 T\u00a0cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus","volume":"31","author":"Park","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib12","first-page":"274","article-title":"Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory musculoskeletal disorders","volume":"31","author":"Pope","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib13","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/kel328","article-title":"Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders","volume":"45","author":"Wolfe","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2016.09.010_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1365-2230.1999.00490.x","article-title":"Herpes zoster in Japanese patients with systemic lupus erythematosus","volume":"24","author":"Ishikawa","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib15","first-page":"1254","article-title":"Herpes zoster in systemic lupus erythematosus","volume":"22","author":"Manzi","year":"1995","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib16","first-page":"84","article-title":"Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome","volume":"21","author":"Kahl","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib17","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/art.1780210710","article-title":"Herpes zoster in patients with systemic lupus erythematosus","volume":"21","author":"Moutsopoulos","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2016.09.010_bib18","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/0961203312470186","article-title":"Increased incidence of herpes zoster among patients with systemic lupus erythematosus","volume":"22","author":"Chakravarty","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.rdc.2016.09.010_bib19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1590\/S1807-59322011000700009","article-title":"Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort","volume":"66","author":"Chen","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.rdc.2016.09.010_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s15010-011-0162-0","article-title":"Risk of herpes zoster inpatients with underlying diseases: a retrospective hospital-based cohort study","volume":"39","author":"Hata","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.rdc.2016.09.010_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/RHU.0b013e3181d52ed7","article-title":"Incidence, risk factors, and outcomes of herpes zoster in systemic lupus erythematosus","volume":"16","author":"Borba","year":"2010","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2016.09.010_bib22","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in auto-immune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.inf.0000226841.03751.1f","article-title":"Herpes zoster in juvenile-onset lupus erythematosus: incidence, clinical characteristics and risk factors","volume":"25","author":"Lee","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.rdc.2016.09.010_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2015.12.059","article-title":"Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): a nationwide case-control study","volume":"75","author":"Hu","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib25","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1016\/j.vaccine.2013.05.085","article-title":"The case for Zostavax vaccination in systemic lupus erythematosus","volume":"31","author":"Cogman","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.rdc.2016.09.010_bib26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s15010-013-0550-8","article-title":"Incidence of herpes zoster in patients with altered immune function","volume":"42","author":"Chen","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.rdc.2016.09.010_bib27","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3899\/jrheum.130170","article-title":"Herpes zoster vaccination in SLE: a pilot study of immunogenicity","volume":"40","author":"Guthridge","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib28","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/acr.22628","article-title":"Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease-modifying antirheumatic drugs","volume":"67","author":"Pappas","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2016.09.010_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/acr.22470","article-title":"Risks of herpes zoster in patients with rheumatoid arthritis according to biologic-disease modifying therapy","volume":"67","author":"Yun","year":"2015","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2016.09.010_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/imj.12679","article-title":"Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumor necrosis factor-a inhibitors","volume":"45","author":"Segan","year":"2015","journal-title":"Intern Med J"},{"key":"10.1016\/j.rdc.2016.09.010_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/annrheumdis-2013-204575","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"73","author":"Ramiro","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jbspin.2013.07.009","article-title":"Risk of herpes\/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis","volume":"81","author":"Che","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.rdc.2016.09.010_bib33","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/annrheumdis-2016-209131","article-title":"Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis","volume":"75","author":"Curtis","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib34","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1002\/art.38745","article-title":"Herpes Zoster and tofacitinib therapy in patients with rheumatoid arthritis","volume":"66","author":"Winthrop","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2016.09.010_bib35","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A\u00a0vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2016.09.010_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2016.09.010_bib37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.mayocp.2015.04.021","article-title":"Risk of herpes zoster and disseminated varicella zoster in patients taking immunosuppressant drugs at the time of zoster vaccination","volume":"90","author":"Cheetham","year":"2015","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.rdc.2016.09.010_bib38","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000743","article-title":"Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression","volume":"22","author":"Wasan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.rdc.2016.09.010_bib39","unstructured":"Safety and Effectiveness Study of the Live Zoster Vaccine in Anti-TNF Users (VERVE). ClinicalTrials.gov identifier: NCT02538757. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02538757?term=verve&rank=2. Accessed July 25, 2016."},{"key":"10.1016\/j.rdc.2016.09.010_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/cei.12809","article-title":"Herpes zoster and the search for an effective vaccine","author":"Arnold","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rdc.2016.09.010_bib41","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N\u00a0Engl J Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16300618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X16300618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:15:04Z","timestamp":1760181304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X16300618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0889857X16300618"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2016.09.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2016.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}